← Open Payments lookup

ELVIN RUIZ: Open Payments

NPI 1568538379 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,993 in 84 payments from 18 companies in 2025. Trend: 2023 $4,491 · 2024 $1,959 · 2025 $1,993

Food & beverage: $1,993
CompanyPaymentsAmount
ABBVIE INC.16$397
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$213
Alkermes, Inc.9$200
Axsome Therapeutics, Inc.5$143
Takeda Pharmaceuticals U.S.A., Inc.7$141
Otsuka America Pharmaceutical, Inc.7$131
E.R. Squibb & Sons, L.L.C.4$120
JAZZ PHARMACEUTICALS INC.3$88
Teva Pharmaceuticals USA, Inc.4$79
Almatica Pharma LLC3$78

Products named: VRAYLAR, CAPLYTA, LYBALVI, TRINTELLIX, REXULTI, COBENFY, Auvelity, XYWAV.

Industry payments across NY — which companies pay providers there.